Yüklüyor......
Targeting the Hepatocyte Growth Factor–cMET Axis in Cancer Therapy
The hepatocyte growth factor (HGF) and its receptor, the transmembrane tyrosine kinase cMET, promote cell proliferation, survival, motility, and invasion as well as morphogenic changes that stimulate tissue repair and regeneration in normal cells but can be co-opted during tumor growth. MET overexpr...
Kaydedildi:
Asıl Yazarlar: | , , |
---|---|
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
American Society of Clinical Oncology
2012
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3434988/ https://ncbi.nlm.nih.gov/pubmed/22869872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.40.3774 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|